Trivium Point Advisory’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,774
Closed -$1.33M 201
2020
Q4
$1.33M Sell
6,774
-281
-4% -$58.1K 0.38% 100
2020
Q3
$1.48M Buy
7,055
+1,877
+36% +$418K 0.52% 70
2020
Q2
$1.15M Buy
5,178
+849
+20% +$170K 0.45% 80
2020
Q1
$784K Buy
+4,329
New +$715K 0.4% 88
2019
Q4
Sell
-1,353
Closed -$203K 162
2019
Q3
$203K Sell
1,353
-18
-1% -$2.85K 0.09% 154
2019
Q2
$210K Sell
1,371
-374
-21% -$57.1K 0.09% 158
2019
Q1
$280K Buy
1,745
+205
+13% +$31.8K 0.13% 136
2018
Q4
$237K Buy
+1,540
New +$240K 0.14% 126

Other funds holding CLX

Trivium Point Advisory's CLX Position: Q1 2021 in Review

Trivium Point Advisory sold out of Clorox (CLX) in Q1 2021, closing a stake of 6,774 shares — an estimated $1.33M sold.

Trivium Point Advisory first reported a position in CLX in Q4 2018 and held it in 8 quarters. The position peaked at $1.48M in Q3 2020. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • Trivium Point Advisory reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • Trivium Point Advisory sold 6,774 Clorox shares in Q1 2021, an estimated $1.33M.
  • Trivium Point Advisory first reported a position in Clorox in Q4 2018 and held it in 8 quarters.
  • Trivium Point Advisory's Clorox position peaked at $1.48M in Q3 2020.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on Trivium Point Advisory's 13F filing for Q1 2021, filed 14 May 2021.